Optimizing Restless Legs Syndrome Care: Integrating Rehabilitation into Multimodal Management.

Area of Science:

• Neurology
• Sleep Medicine

Background:

• Restless Legs Syndrome (RLS) is a prevalent neurological disorder.
• Its exact cause is unknown but linked to genetics, iron deficiency, and dopaminergic dysfunction.
• RLS is diagnosed using the International Restless Legs Syndrome Study Group (IRLSSG) criteria.

Purpose of the Study:

• To review current and emerging treatment options for Restless Legs Syndrome.
• To provide an overview of pharmacological and non-pharmacological management strategies.
• To highlight novel therapeutic approaches in experimental stages.

Main Methods:

• Literature review of RLS pathophysiology and treatment modalities.
• Compilation of established non-pharmacological interventions.
• Summary of current pharmacological treatments.
• Overview of experimental therapies.

Main Results:

• Non-pharmacological options include lifestyle adjustments, exercises, physical modalities, and mind-body practices.
• Pharmacological treatments involve gabapentinoids, dopamine agonists, opioids, and iron therapy.
• Emerging treatments such as nerve stimulation and brain stimulation are under investigation.

Conclusions:

• RLS management is multifaceted, encompassing diverse treatment strategies.
• A combination of approaches may be necessary for effective RLS symptom control.
• Ongoing research into novel therapies holds promise for future RLS management.